CVS · Categories · Upgrades
CVS - Analyst upgrades
CVS Health Corporation (CVS) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for CVS
- CVS Health upgraded by Bernstein with a new price targetBernstein upgraded CVS Health from Mkt Perform to Outperform and set a new price target of $94.00
- CVS Health upgraded by UBS with a new price targetUBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00
- CVS Health upgraded by Robert W. Baird with a new price targetRobert W. Baird upgraded CVS Health from Neutral to Outperform and set a new price target of $82.00
- CVS Health upgraded by Leerink Partners with a new price targetLeerink Partners upgraded CVS Health from Market Perform to Outperform and set a new price target of $75.00 from $55.00 previously
- CVS Health upgraded by Cantor FitzgeraldCantor Fitzgerald upgraded CVS Health from Neutral to Overweight
- CVS Health upgraded by Edward JonesEdward Jones upgraded CVS Health from Hold to Buy
- CVS Health upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded CVS Health from Hold to Buy and set a new price target of $66.00
- CVS Health upgraded by Wells Fargo with a new price targetWells Fargo upgraded CVS Health from Equal Weight to Overweight and set a new price target of $66.00 from $60.00 previously
- CVS Health upgraded by Barclays with a new price targetBarclays upgraded CVS Health from Equal Weight to Overweight and set a new price target of $82.00 from $63.00 previously
- CVS Health upgraded by TD Cowen with a new price targetTD Cowen upgraded CVS Health from Hold to Buy and set a new price target of $85.00 from $59.00 previously
- CVS Health upgraded by Evercore ISI with a new price targetEvercore ISI upgraded CVS Health from In-line to Outperform and set a new price target of $83.00 from $81.00 previously
- CVS Health upgraded by Wolfe Research with a new price targetWolfe Research upgraded CVS Health from Peer Perform to Outperform and set a new price target of $80.00